| PLGA–mPEG nanoparticles of cisplatin: in vitro nanoparticle degradation, in vitro drug release and in vivo drug residence in blood properties K Avgoustakis, A Beletsi, Z Panagi, P Klepetsanis, AG Karydas, ... Journal of controlled release 79 (1-3), 123-135, 2002 | 641 | 2002 |
| PLGA–mPEG nanoparticles of cisplatin: in vitro nanoparticle degradation, in vitro drug release and in vivo drug residence in blood properties K Avgoustakis, A Beletsi, Z Panagi, P Klepetsanis, AG Karydas, ... Journal of controlled release 79 (1-3), 123-135, 2002 | 641 | 2002 |
| Pegylated poly (lactide) and poly (lactide-co-glycolide) nanoparticles: preparation, properties and possible applications in drug delivery K Avgoustakis Current drug delivery 1 (4), 321-333, 2004 | 548 | 2004 |
| Chitosan nanoparticles loaded with dorzolamide and pramipexole S Papadimitriou, D Bikiaris, K Avgoustakis, E Karavas, M Georgarakis Carbohydrate polymers 73 (1), 44-54, 2008 | 322 | 2008 |
| Effect of copolymer composition on the physicochemical characteristics, in vitro stability, and biodistribution of PLGA–mPEG nanoparticles K Avgoustakis, A Beletsi, Z Panagi, P Klepetsanis, E Livaniou, ... International journal of pharmaceutics 259 (1-2), 115-127, 2003 | 286 | 2003 |
| Effect of dose on the biodistribution and pharmacokinetics of PLGA and PLGA–mPEG nanoparticles Z Panagi, A Beletsi, G Evangelatos, E Livaniou, DS Ithakissios, ... International journal of pharmaceutics 221 (1-2), 143-152, 2001 | 284 | 2001 |
| Investigation of the release mechanism of a sparingly water-soluble drug from solid dispersions in hydrophilic carriers based on physical state of drug, particle size … E Karavas, E Georgarakis, MP Sigalas, K Avgoustakis, D Bikiaris European journal of pharmaceutics and biopharmaceutics 66 (3), 334-347, 2007 | 263 | 2007 |
| Anticancer activity of cisplatin-loaded PLGA-mPEG nanoparticles on LNCaP prostate cancer cells EC Gryparis, M Hatziapostolou, E Papadimitriou, K Avgoustakis European journal of pharmaceutics and biopharmaceutics 67 (1), 1-8, 2007 | 195 | 2007 |
| Biodistribution properties of nanoparticles based on mixtures of PLGA with PLGA–PEG diblock copolymers A Beletsi, Z Panagi, K Avgoustakis International journal of pharmaceutics 298 (1), 233-241, 2005 | 134 | 2005 |
| Poly (lactide)‐poly (ethylene glycol) micelles as a carrier for griseofulvin E Pierri, K Avgoustakis Journal of Biomedical Materials Research Part A: An Official Journal of The …, 2005 | 121 | 2005 |
| Physiologically based pharmacokinetic modeling of PLGA nanoparticles with varied mPEG content M Li, Z Panagi, K Avgoustakis, J Reineke International journal of nanomedicine, 1345-1356, 2012 | 113 | 2012 |
| In vivo investigation of tolerance and antitumor activity of cisplatin-loaded PLGA-mPEG nanoparticles G Mattheolabakis, E Taoufik, S Haralambous, ML Roberts, K Avgoustakis European Journal of Pharmaceutics and Biopharmaceutics 71 (2), 190-195, 2009 | 112 | 2009 |
| Effect of thymosin peptides on the chick chorioallantoic membrane angiogenesis model V Koutrafouri, L Leondiadis, K Avgoustakis, E Livaniou, J Czarnecki, ... Biochimica et Biophysica Acta (BBA)-General Subjects 1568 (1), 60-66, 2001 | 111 | 2001 |
| Effect of preparative variables on the properties of poly (dl-lactide-co-glycolide)–methoxypoly (ethyleneglycol) copolymers related to their application in controlled drug delivery A Beletsi, L Leontiadis, P Klepetsanis, DS Ithakissios, K Avgoustakis International journal of pharmaceutics 182 (2), 187-197, 1999 | 100 | 1999 |
| Graphene oxide stabilized by PLA–PEG copolymers for the controlled delivery of paclitaxel A Angelopoulou, E Voulgari, EK Diamanti, D Gournis, K Avgoustakis European Journal of Pharmaceutics and Biopharmaceutics 93, 18-26, 2015 | 91 | 2015 |
| Effect of conditions of preparation on the size and encapsulation properties of PLGA-mPEG nanoparticles of cisplatin EC Gryparis, G Mattheolabakis, D Bikiaris, K Avgoustakis Drug delivery 14 (6), 371-380, 2007 | 81 | 2007 |
| Polylactic-co-glycolic acid (PLGA) K Avgoustakis Encyclopedia of biomaterials and biomedical engineering 1 (1), 1-11, 2005 | 77 | 2005 |
| Facile synthesis of polyester-PEG triblock copolymers and preparation of amphiphilic nanoparticles as drug carriers AA Vassiliou, SA Papadimitriou, DN Bikiaris, G Mattheolabakis, ... Journal of Controlled Release 148 (3), 388-395, 2010 | 60 | 2010 |
| Folic acid-functionalized, condensed magnetic nanoparticles for targeted delivery of doxorubicin to tumor cancer cells overexpressing the folate receptor A Angelopoulou, A Kolokithas-Ntoukas, C Fytas, K Avgoustakis ACS omega 4 (26), 22214-22227, 2019 | 58 | 2019 |
| Transcutaneous delivery of a nanoencapsulated antigen: induction of immune responses G Mattheolabakis, G Lagoumintzis, Z Panagi, E Papadimitriou, ... International journal of pharmaceutics 385 (1-2), 187-193, 2010 | 56 | 2010 |
